AI may have just reignited the biotech bull market
Everyone is watching AI. Fewer people are noticing where some of that money may be going next. Biotech quietly spent the last few years getting crushed after the pandemic boom faded. Many companies lost 50% to 90% of their value, capital dried up, and investors largely stopped paying attention. Now the mood feels different. Money …